A Study of Barzolvolimab in Patients With Atopic Dermatitis

Status:
RECRUITING

Trial end date:
2027-05-01

Target enrollment:

Participant gender:

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis

PHASE2

Celldex Therapeutics